DobbieJ.W., TasiauxN., MeijersP.Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease.Br J Rheum1994; 33: 508–19.
TopleyN.What is the ideal technique for testing the biocompatibility of peritoneal dialysis solutions.Perit Dial Int1995; 15(7)(Suppl): S101–8.
11.
Di PaoloN., GarosiG., BiagioliM.Effects of dialysis fluid on cultured mesothelial cells.Perit Dial Int1994; 14(Suppl 3): S12–15.
12.
MarshallB.C., SantanaA., XuQ.D.Metallo proteinases and tissue inhibitor of metalloproteinase in mesothelial cells.J Clin Invest1993; 91: 1792–9.
13.
CannistraS.A., OttensmeierC., TidyT., DefransoB.Vascular cell adhesions molecule-l expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes.Exp Hematol1994; 22: 996–1002.
14.
LinJ.J., PartonL., BeveketG., WadhwaN.K.Plasminogen activator inhibitor-l and peritoneal transport in diabetic and non-diabetic peritoneal dialysis patients.Clin Nephrol1995; 44(5): 310–15.
15.
GotloibL., ShostakA.Large mesothelial cells in peritoneal dialysis: A sign of degeneration of adaptation.Perit Dial Int1996; 16: 118–20.
16.
KumanoK., ShimodaM., HyodoT., SakaiT.The role of TGF-β in growth inhibition of peritoneal mesothelial cells in high -glucose dialysate.Perit Dial Int1995; 15(7)(Suppl): S93–5.
17.
SelgasR., Fernandez-ReysM.J., BasqueE.Functionallongevity of the human peritoneum. How long is continuous peritoneal dialysis possible? Results of a prospective medium-Iong study.Am J Kidney Dis1994; 1: 23, 64–73.
18.
StruijkD.G., KredietR.T., KoomenG.C.A prospective study of peritoneal transport in CAPD patients.Kidney Int1994; 45: 1739–44.
19.
LoW.K., BrendolanA., ProwantB.F., MooreH.L., KhannaR., TwardowskiZ.J.Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients.J Am Soc Nephrol1994; 4: 1466–74.
20.
HeimbürgerO., WaniewskiA.J., WerynskiA.Peritoneal transport characteristics in CAPD patients with permanent loss of ultrafiltration.Kidney Int1990; 38: 495–506.
21.
PannekeetM.A., ZemelD., Koomen, StruijkD.G., KredietR.T.Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.Perit Dial Int1995; 15: 217–25.
22.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 177–83.
23.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 184–91.
24.
HabatchG., BloembergenW.E., MaugerE.A., WolfeR.A., PortF.K.Hospitalization among United States dialysis patients: Hemodialysis versus peritoneal dialysis.J Am Soc Nephrol1995; 5: 1940–8.
